Delavirdine

Results: 36



#Item
31HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT® safely and effectively. See full prescribing information for EDURANT. EDURANT (rilpivirine) tablets for or

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT® safely and effectively. See full prescribing information for EDURANT. EDURANT (rilpivirine) tablets for or

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-05-02 15:03:35
32HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVIRASE safely and effectively. See full prescribing information for INVIRASE. INVIRASE© (saquinavir mesylate) Cap

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVIRASE safely and effectively. See full prescribing information for INVIRASE. INVIRASE© (saquinavir mesylate) Cap

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-10-12 12:02:16
33Methergine (methylergonovine maleate) injection label

Methergine (methylergonovine maleate) injection label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-06-26 12:14:04
34HIVInfo.us - Lexiva - fosamprenavir information

HIVInfo.us - Lexiva - fosamprenavir information

Add to Reading List

Source URL: www.hivinfo.us

Language: English - Date: 2005-01-16 19:27:54
35HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVIRASE safely and effectively. See full prescribing information for INVIRASE.  •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVIRASE safely and effectively. See full prescribing information for INVIRASE. •

Add to Reading List

Source URL: www.gene.com

Language: English - Date: 2014-03-31 07:24:10
36JOURNAL OF CLINICAL MICROBIOLOGY, May 2004, p. 2353–[removed]/$08.00⫹0 DOI: [removed]JCM[removed]–[removed]Vol. 42, No. 5  Weak Agreement between Antivirogram and PhenoSense Assays in

JOURNAL OF CLINICAL MICROBIOLOGY, May 2004, p. 2353–[removed]/$08.00⫹0 DOI: [removed]JCM[removed]–[removed]Vol. 42, No. 5 Weak Agreement between Antivirogram and PhenoSense Assays in

Add to Reading List

Source URL: compbio.washington.edu

Language: English - Date: 2004-05-07 21:56:41